RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Good to hear from Benj Gallender promoting DMSure... $19M per Quarter x 4 Quarters = $76M for the year.... given ongoing Covid testing needs and growing AI potential creating expected future international growth I am using a valuation multiple of 4 is $76M x 4 = $304M, which when divided by 293M shares is a share price valuation of $1.04 per share. So to get $0.80 you need only a multiple of 3 or annual rev of $58.5 using a multiple of 4... my uneducated, simpleton calculation... but the Germany analysis is far more complicated accurate that was done a few months ago before Q1 were published and they gave a current valuation of $0.87 CAD as a conservative low and well over $1 on a higher valuation... Also account for multiple offers to be acquired... that holds value to add to the valuation... No one should use this for any decision making... it is my own personal opinion and could be completely inaccurate about how to valuation an SP... All IMO. DYODD.